Question 1

Does Alkeon Capital Management own RYTM stock?

Accepted Answer

No. Alkeon Capital Management exited its RYTM (Rhythm Pharmaceuticals) position in Q4 2025. Its Q3 2025 13F listed 1,017,700 shares worth $102.8M.

Question 2

How many shares of RYTM does Alkeon Capital Management own?

Accepted Answer

None since Q4 2025, when Alkeon Capital Management exited the position. Its Q3 2025 13F listed 1,017,700 shares worth $102.8M.

Question 3

What is Alkeon Capital Management's RYTM position worth?

Accepted Answer

Alkeon Capital Management's RYTM position was worth $102.8M in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Alkeon Capital Management buying or selling RYTM?

Accepted Answer

In Q4 2025, Alkeon Capital Management exited its entire RYTM position.

Question 5

When did Alkeon Capital Management first buy RYTM?

Accepted Answer

Alkeon Capital Management first reported RYTM in its Q2 2022 13F and listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$107.04	0
2025-Q3	Unchanged	1M	0.0%	$102.8M	0.2%	$100.99	0
2025-Q2	Increased	1M	+24.5%	$64.3M	0.1%	$63.19	43
2025-Q1	Decreased	817,700	-30.0%	$43.3M	0.1%	$52.97	0
2024-Q4	Unchanged	1.2M	0.0%	$65.4M	0.1%	$55.98	0
2024-Q3	Increased	1.2M	+16.8%	$61.2M	0.1%	$52.39	41